Log In
BCIQ
Print this Print this
 

CEN-209

  Manage Alerts
Collapse Summary General Information
Company Varian Medical Systems Inc.
DescriptionAdjunct to chemotherapy or radiotherapy regimens that is selectively activated in areas of low oxygen in solid tumors
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
PartnerCancer Research Technology Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
Get a free BioCentury trial today